background image

Paid Clinical Trials Philadelphia

Discover 2,107 paid clinical trials in Philadelphia, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Recruiting
PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Philadelphia PA, New York NY, Baltimore MD, Boston MAshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

Study of Olutasidenib and Temozolomide in HGG

Recruiting
PHASE2

Sponsor:

Rigel Pharmaceuticals

Location:

Philadelphia PA, Washington DC, Boston MA, Torontoshow 8 more

Code:

NCT06161974

Conditions

High Grade Glioma

Astrocytoma

Astrocytoma, Grade III

Astrocytoma, Grade IV

Diffuse Intrinsic Pontine Glioma

Eligibility Criteria

Sex: All

Age: 12 - 39

Healthy Volunteers: Not accepted

Interventions

Olutasidenib + TMZ

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Bala-Cynwyd PA, New Brunswick NJ, Lancaster PA, New York NYshow 29 more

Code:

NCT06319820

Conditions

Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAR-210

Gemcitabine

MMC

Study of LP-184 in Patients with Advanced Solid Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Lantern Pharma Inc.

Location:

Philadelphia PA, Baltimore MD, Louisville KY, Indianapolis INshow 5 more

Code:

NCT05933265

Conditions

Advanced Solid Tumor

Metastatic Solid Tumor

GBM

TNBC - Triple-Negative Breast Cancer

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LP-184

Spironolactone

Olaparib

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

Recruiting

Sponsor:

Thomas Jefferson University

Location:

Philadelphia PA

Code:

NCT01514565

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting
PHASE3

Sponsor:

Incyte Corporation

Location:

Philadelphia PA, Yardley PA, Brooklyn NY, New York NYshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

Measuring Pain Experience in Individuals With Lateral Elbow Tendinopathy

Recruiting

Sponsor:

Thomas Jefferson University

Location:

Philadelphia PA, Cherry Hill NJ, Rockledge PA, Torresdale PAshow 9 more

Code:

NCT06025565

Conditions

Elbow Tendinopathy

Tendinopathy

Tennis Elbow

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pain Experience Measures

Study with Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure with Severely Reduced Ejection Fraction

Recruiting
PHASE3

Sponsor:

Cytokinetics

Location:

Bridgewater NJ, Camp Hill PA, Greensboro NC, Marion OHshow 9 more

Code:

NCT06736574

Conditions

Heart Failure

Heart Failure with Reduced Ejection Fraction

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Omecamtiv Mecarbil (OM)

Placebo

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

Recruiting
PHASE2
PHASE3

Sponsor:

Biogen

Location:

Philadelphia PA, Hershey PA, Brooklyn NY, New York NYshow 51 more

Code:

NCT05531565

Conditions

Subacute Cutaneous Lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Litifilimab

Placebo

Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms

Recruiting
PHASE3

Sponsor:

The Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust

Location:

Philadelphia PA

Code:

NCT00094874

Conditions

Interstitial Cystitis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Acupuncture

Philadelphia boasts a strong healthcare network and prominent medical research centers, making it a pivotal location for a diverse range of clinical trials. Renowned institutions such as the University of Pennsylvania, Thomas Jefferson University, and Temple University lead the way in innovative research. These centers are known for their cutting-edge studies across various fields, including oncology, cardiology, neurology, and infectious diseases.

The city’s rich tapestry of clinical research is supported by its diverse population, while the collaborative research environment in Philadelphia also fosters groundbreaking discoveries that can transform patient care and improve health outcomes on a broader scale.

Why choose Philadelphia for clinical trials?

Common conditions studied in Philadelphia

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Philadelphia